Background--Although increased amounts of reactive oxygen species in the pathogenesis of abdominal aortic aneurysm (AAA) are well documented, the precise molecular mechanisms by which reactive oxygen species induce AAAs have not been fully elucidated. This study focused on the role of hydrogen peroxide-inducible clone 5 (Hic-5), which is induced by hydrogen peroxide and transforming growth factor-b, in the cellular signaling of AAA pathogenesis.
A bdominal aortic aneurysm (AAA) is an age-associated disease that affects approximately 5% of elderly individuals and is responsible for a significant number of deaths in Western countries. 1 Oxidative stress, generated by excessive reactive oxygen species (ROS), has been shown to play causal roles in AAAs. 2, 3 Animal models deficient in ROS-generating enzymes, such as inducible nitric oxide synthase, NADPH oxidase-1, and p47phox, clearly demonstrated preserved aortic wall morphology and attenuated AAA development. [4] [5] [6] Increased activities of matrix metalloproteinases (MMPs) play a key mechanical role in the formation of AAAs. 7, 8 A strong mechanistic link exists between increased ROS production and MMP activity. As has been reported recently, angiotensin II (Ang II) induces the generation of ROS in vascular smooth muscle cells (VSMCs), which triggers the activation of MMPs and vascular inflammatory responses, thereby promoting the formation of AAAs in an animal model. 2, 9 However, little is known about the detailed signaling pathways that regulate these processes. Hydrogen peroxide-inducible clone 5 (Hic-5), originally identified as a gene induced by H 2 O 2 as well as transforming growth factor-b1 (TGF-b1), has been shown to serve as a focal adhesion protein that belongs to the paxillin family. 10 We recently successfully generated Hic-5-deficient mice, which were viable and fertile and had no obvious abnormalities.
The molecular basis of Hic-5 and its implications in various pathophysiological conditions including vascular remodeling have already been described. 11, 12 However, whether Hic-5 is involved in AAA formation is unknown. In this study, we analyzed the potential role of Hic-5 in AAA formation. We found that AAA formation and rupture were almost completely prevented in Hic-5-deficient mice. Mechanistic studies showed that Hic-5 served as a novel scaffold protein to regulate c-Jun N-terminal kinase (JNK) pathway activation, which resulted in MMP expression and activation in VSMCs and the subsequent formation of AAAs.
Methods

Generation of Mice
All experiments were conducted in accordance with the protocols approved by the Institutional Committee for Animal Research of Showa University. All of the mice were bred in C56BL/6 background genotype. Apoe
À/À
Hic-5 À/À mice were generated by crossing Hic-5 À/-mice with Apoe À/À mice. For the generation of smooth muscle (SM)-specific knockout mice for Hic-5 (SM-Hic-5KO), we used our previously produced mouse strain in which all exons of Hic-5 were floxed (Hic-5 F/F ). 11 Hic-5 F/F mice were intercrossed with a transgenic mouse line expressing inducible SM-specific Cre recombinase with a modified estrogen receptor binding domain (CreER T2 ) under the control of the SM-specific SM myosin heavy chain promoter (SMMHC). 13 The SMMHC-Cre gene is located on the Y chromosome in this mouse line, and only male offspring carried the SMMHC-Cre gene. Hic-5 F/F /sCre Y+ mice (5 to 6 weeks old) were injected with tamoxifen (1 mg/day IP) on 5 consecutive days. The day of the last tamoxifen injection was defined as day 0. The Ang II treatment was performed for 4 weeks from day 55 after the tamoxifen injection. All animals were housed under a 12-hour light/12-hour dark regimen and consumed on a normal chow diet.
The Mouse Model of Ang II-Induced Aortic Aneurysm
The mouse model of Ang II-induced aneurysm formation has been previously described. 14 Ang II was infused via the use of ALZET model 2004 osmotic pumps (ALZA Corp) at 1000 ng/ kg per minute. After 4 weeks of infusion, aneurysm size was evaluated by measuring maximal abdominal aortic diameters with a digital caliper. Systolic blood pressure was measured in conscious mice by using the tail-cuff method (MK-2000;
Muromachi Kikai Co). Serum total cholesterol concentrations were determined by using a cholesterol determination kit (Wako Chemicals).
Histological Analysis
After the animals were killed, their aortas were perfused with 10% phosphate-buffered formalin for 5 minutes. Whole aortas were harvested and fixed with 10% formalin for 24 hours. The aortas were cut and embedded in paraffin or OCT compound for the preparation of cross sections (5 lm). Paraffin sections were stained with hematoxylin and eosin (H&E) staining and Victoria Blue H&E staining or used for immunostaining. Frozen sections were used for immunofluorescence.
Immunohistochemistry
Formaldehyde-fixed paraffin sections and frozen sections were incubated with primary antibodies overnight at 4°C. The primary antibodies used were Hic-5 monoclonal (BD Biosciences), a-SM actin monoclonal (Sigma-Aldrich), and rat anti-mouse macrophage-monocyte specific monoclonal (AbD Serotec). As a negative control, isotype-matched antibodies were used in place of the primary antibodies. Slides were viewed with use of a microscope (IX70; Olympus) and digital camera (DP72; Olympus). Immunofluorescence images were captured and analyzed with Lumina vision software (Mitani Visual System).
Harvest of Mouse Aortic VSMCs
The preparation of mouse aortic VSMCs was performed as previously described. 11 In brief, aortas were isolated from Hic-5 +/+ and Hic-5 À/À mice, followed by separation of tunica media from the adventitia and endothelium. The cells were dispersed in collagenase and elastase and maintained in Dulbecco's modified Eagle's medium. Passage 2 to 8 VSMCs were used for experiments.
Western Blotting
VSMCs were harvested on ice-cold lysis buffer. In some experiments, VSMCs were infected with adenovirus encoding Hic-5 (Ad-hic-5/flag) or b-galactosidase (Ad-b-gal) as a control. Aortic tissue samples were crushed with a biomasher (Nippi) and lysed in lysis buffer. Equal amounts of protein were separated by 10% SDS-PAGE. Immunodetection was performed using the following primary antibodies: Hic-5; GAPDH and MMP2 (Santa Cruz Biotechnology), membrane type 1 (MT1)-MMP (Sigma-Aldrich); extracellular signal-regulated kinase (ERK), p38, mitogen-activated protein kinase kinase (MAPKK; also known as MKK) 4, MKK7, and their phosphorylated (P) forms (P-ERK, P-p38, P-MKK4, P-MKK7, and P-JNK1/2) (Cell Signaling); and JNK1/2 (Santa Cruz Biotechnology). The densities of the bands were measured using Light-Capture and Densitograph software (AE-6962FC, CS Analyzer version 2.0; ATTO).
Gelatin Zymography and In Situ Zymography
The evaluation of MMP activities in response to Ang II was performed as described previously. 9, 15 To analyze the role of Hic-5 in Ang II-induced MMP activation, VSMCs were treated with Ang II (1 lmol/L) for 24 hours. Aortas from Apoe
and Apoe À/À Hic-5 À/À mice infused with Ang II for 7 days were incubated in culture medium for 20 hours. The medium was then collected and centrifuged to remove cell debris. The conditioned medium was concentrated and electrophoresed in SDS-PAGE gels containing gelatin (Sigma-Aldrich). Gels were washed in 2.5% Triton X-100 and incubated overnight in zymography buffer (50 mmol/L Tris, pH 7.4, 10 mmol/L CaCl 2 ) at 37°C. Gels were subsequently stained with Coomassie brilliant blue. For in situ zymography, freshly cut frozen aortic sections (10 lm) were incubated with a fluorogenic gelatin substrate (DQ gelatin; Invitrogen) dissolved to 25 mg/mL in zymographic buffer. Proteolytic activity was detected as green fluorescence with microscopy (IX70; Olympus, Japan). Negative control zymograms were incubated in the presence of 5 mmol/L EDTA.
Immunoprecipitation
Aortic media were lysed in RIPA buffer containing a mixture of proteinase inhibitors and 1 mmol/L sodium vanadate for immunoprecipitation studies. Dynabeads (Invitrogen) conjugated with an antibody against Hic-5 or control mouse IgG (Santa Cruz Biotechnology) were added to the lysates (5 lg per sample) and rotated at room temperature for 60 minutes. Samples were washed with RIPA buffer 3 times and soaked in elution buffer for 10 minutes. Immunoprecipitated proteins were then processed for SDS-PAGE and Western blot analysis.
In Situ Proximity Ligation Assay
The in situ proximity ligation assay (PLA) method allows the subcellular colocalization of protein-protein interactions to be determined. 16, 17 Mouse VSMCs were cultured in cover glasses. After culture in serum-free medium for 24 hours, VSMCs were treated with or without Ang II for 10 minutes. VSMCs were then washed in PBS and fixed with 4% paraformaldehyde for 15 minutes. PLA assays were performed as recommended by the manufacturer (OLink Biosciences). Red fluorescent spots were then visualized with microscopy (IX70; Olympus). The negative control was performed without primary antibodies.
Electron Microscopic Observations
Immunoelectron microscopy was performed as previously described. 11 Briefly, sections of mouse aortas were incubated overnight with primary antibodies at 4°C. After the sections were washed with PBS, 10-nm gold-labeled sheep anti-mouse IgG and 15-nm gold-labeled goat anti-rabbit IgG secondary antibodies (BBI International) were used; subsequently, sections were evaluated with Hitachi H-7600 transmission electron microscope.
Statistical Analyses
The data are presented as meanAESEM. (Table) . No significant difference in cholesterol levels was observed between these 2 groups after Ang II infusion (Table) .
No aneurysm was detected in either group after saline infusion ( Figure 1A ). Ang II infusion markedly induced AAAs in 87% (13/15) of Apoe À/À mice ( Figure 1A and 1C), while only
We also noted that maximal aortic diameter ( Figure 1B Apoe À/À mice showed arterial rupture and massive bleeding in the abdominal cavities ( Figure 1F and 1G). In Victoria Blue H&E staining, which specifically demonstrates elastic fibers in the background of H&E-stained tissues, the elastic lamina was extensively disrupted and degraded in Apoe À/À mice. In contrast, Hic-5 deficiency completely prevented the elastic lamina from degradation ( Figure 1G ). These results suggest that protection from elastin degradation is a key mechanism for the inhibition of Ang II-induced AAA formation in
VSMC-Derived Hic-5 Was Required for AAA Formation
We first investigated the expression of Hic-5 in aortic tissues from normal and Ang II-infused Apoe À/À mice. Consistent with our previous report, 12, 18 Hic-5 was highly expressed in SM cells (SMCs) in addition to endothelium ( Figure 2A ) but not in macrophages in the aortas of Apoe À/À mice after the Ang II treatment for 7 days or 4 weeks ( Figure 2B and 2C). The expression pattern of Hic-5 was similar to that of a-SM actin in both normal aorta and AAA lesions, which was consistent with our previous report. 18 Although macrophages have been reported to have a crucial role in the development of Ang II-induced AAAs, 19 Hic-5 was not detected by immunostaining in the macrophages of AAA lesions (Figure 2B ) or by Western blotting analyses in cultured macrophages (data not shown).
To obtain direct evidence for the key role of VSMC-derived Hic-5 in AAA formation, we created SM-specific Hic-5 knockout mice (SM-Hic-5 KO). We used a transgenic mouse line, which expressed in an SMC-specific manner a tamoxifeninducible Cre recombinase under the control of the SMMHC promoter, 13 bred to the well-established Hic-5 floxed mouse line. 11 Hic-5 flox/flox /SMMHC-Cre Y+ (Hic-5 F/F /sCre Y+ ) mice (see "Methods" for details) were treated with tamoxifen as shown in Figure 3A . As a control, we used Hic-5 F/F /sCre Y+ mice to which tamoxifen was not administered. The successful SMC-specific deletion of Hic-5 in the aortic media was shown by Western blotting after the tamoxifen treatment ( Figure 3B ). Cre expression in this mouse line has previously been shown to be specific for vascular and visceral SMCs. 13 We also noted that tamoxifen treatment suppressed Hic-5 expression in the colon ( Figure 3B ) but not in the lung. Hic-5 was expressed mainly in the endothelium and pneumocytes rather than SMCs in the mouse lung (data not shown). By crossing male Hic-5 F/F /sCre Y+ mice with female Apoe
Hic-5 F/F /sCre Y+ mice were generated. The Ang II treatment was performed from day 55 after the tamoxifen injection ( Figure 3A ) using tamoxifen-injected Apoe À/À mice as a control. The successful SMC-specific deletion of Hic-5 in tamoxifen-injected Apoe À/À Hic-5 F/F /sCre Y+ mice was confirmed with use of Western blotting assay of the aortic media after the Ang II treatment, which showed a 98% reduction in Hic-5 protein levels after the tamoxifen treatment ( Figure 3D ). In contrast, Hic-5 expression in the aortic media from Apoe À/À mice was not affected by tamoxifen. Systolic blood pressure and total cholesterol levels were not significantly different between the 2 groups (Table) . Although total cholesterol levels were decreased after the tamoxifen treatment in Apoe We next examined the effects of Ang II on Hic-5 expression in the aorta from Apoe À/À mice and cultured aortic VSMCs.
Hic-5 levels in aortic tissues were significantly enhanced in Apoe À/À mice in the early stage of Ang II infusion ( Figure 4A ).
Hic-5 expression was also increased by Ang II in a concentration-dependent manner in cultured mouse aortic VSMCs ( Figure 4B ). As was previously reported, Ang II increased the amount of NADPH oxidase-derived ROS in aortic VSMCs. 21, 22 Pretreatment with ROS scavenger N-acetyl-L-cysteine markedly reduced Ang II-induced Hic-5 expression ( Figure 4B ).
Hic-5 Deficiency Prevented Ang II-Induced MMP Expression and Activation in VSMCs
Among the MMPs, VSMC-derived MMP-2, which is cleaved by MT1-MMP into active MMP2, and macrophage-derived MMP9 were shown to work in concert to degrade extracellular matrix, thereby promoting AAA formation and rupture. 7, 23 Ang II has been shown to stimulate the secretion and activation of MMP2 in VSMCs during AAA formation. 9, 24, 25 Ang II infusion for 7 days in Apoe À/À mice markedly increased the expression of proMMP2 and activated MMP2 in the aortic media ( Figure 5A ). The induction of these 2 MMP2 proteins by Ang II infusion was significantly weaker in Apoe À/À Hic-5 À/À mice than in Apoe À/À mice ( Figure 5A and 5B). We next focused on MT1-MMP, a major activator of proMMP2. Basal expression of MT1-MMP was negligible in the aortic media from both Apoe À/À and Apoe À/À Hic-5 À/À mice. The Ang II treatment increased MT1-MMP protein expression in both groups; however, the induction of MT1-MMP was significantly attenuated in Apoe À/À Hic-5 À/À mice ( Figure 5A and 5C). Gelatin zymography of the aortas from Apoe À/À showed an increase in proMMP2 and activated MMP2. In contrast, Ang II-treated aortas from Apoe À/À Hic-5 À/À mice showed markedly reduced MMP2 expression and activation ( Figure 5D ). We obtained a similar result by in situ zymography, which showed that Ang II infusion markedly increased MMP activity in the medial layers of Apoe À/À mice but not in Apoe À/À Hic-5 À/À mice ( Figure 5E ). MMP activity was negligible in both Apoe
and Apoe À/À Hic-5 À/À mice after saline infusion ( Figure 5E ).
We also observed that the Ang II treatment induced the expression of MT1-MMP and MMP2 in cultured VSMCs isolated from Hic-5 +/+ mice, whereas VSMCs from Hic-5 À/À mice did not exhibit such an upregulation ( Figure 5F and 5G).
As shown with gelatin zymography, the secretion and activation of MMP2 in the culture media were lower in Hic-5 À/À VSMCs than in Hic-5 +/+ VSMCs ( Figure 5F , lower panel). In contrast to
VSMCs, macrophages did not express Hic-5. As expected, no significant difference in MMP9 production was observed for macrophages from Hic-5 +/+ and Hic-5 À/À mice (data not shown).
Hic-5 Regulated Phosphorylation of the JNK Pathway in VSMCs
We next analyzed the mechanism for decreases in MMP secretion and activation by Hic-5 deficiency. Although the enhanced production of ROS and associated vascular inflammation are known to accelerate Ang II-induced MMP induction and subsequent AAA development and progression, 2,5,26 we found that Hic-5 deficiency in Apoe À/À mice did not affect Ang II-induced ROS production or the secretion of proinflammatory cytokines and chemokines in cultured VSMCs and isolated aortas (data not shown). The JNK pathway was previously shown to upregulate the expression of MMPs including MMP2 and MT1-MMP. 17, 27 We next investigated whether Hic-5 was required for JNK activation by phosphorylation. VSMCs from Hic-5 +/+ and Hic-5 À/À mice were treated with Ang II at the indicated times, and the phosphorylation of JNK was analyzed ( Figure 6A ). We used anisomycin, a potent stimulator of JNK, as a positive control. 28 Figure 5A Figure 6D ). We next examined whether Hic-5 served as a component of the JNK pathway. JNK protein kinases are activated by phosphorylation by MKK4 and MKK7, which are well known as adjacent upstream kinases of JNK. 29, 30 We found that Hic-5 deficiency hardly affected the phosphorylation of MKK7 (data not shown). However, the phosphorylation of MKK4 was significantly higher in Hic-5 À/À VSMCs than in Hic-5 +/+ VSMCs, even at basal levels ( Figure 6E ).
Hic-5 Is Associated Directly With MKK4 and JNK
The specificity of signal transduction depends on specific protein-protein interactions. Scaffold proteins, including the JNK interacting protein group bind to MKK4 and/or MKK7, in addition to JNK, and coordinate signal transduction in the JNK pathway. 30, 31 As described previously, Hic-5 serves as a scaffold of integrin signaling through interactions with multiple signaling molecules. 12 Because Hic-5 deficiency led to the decreased phosphorylation of p54 JNK and increased phosphorylation of MKK4, we reasoned that Hic-5 may serve as a scaffold protein between MKK4 and p54 JNK. To test this possibility, we performed immunoprecipitation experiments using an Hic-5-specific antibody and aortic tissue lysate from Hic-5 +/+ mice. The results showed that the Hic-5 antibody pulled down JNK, especially p54 JNK and MKK4, but not MKK7, p38, or ERK together with Hic-5 ( Figure 7A ). Using the specific antibody of JNK1 and JNK2, we found that JNK2 is primarily composed of the p54 JNK isoform in cultured mouse VSMCs (data not shown).
To further validate the association of Hic-5 with p54 JNK or MKK4 in Hic-5 +/+ VSMCs, we performed in situ proximity ligation assays, which identify the subcellular localization of interacting endogenous proteins within approximately 40 nm at single molecule resolution. 
The colocalization of these molecules was further demonstrated by using an immunoelectron microscopic method in aortas from Hic-5 +/+ mice ( Figure 7C ). We next analyzed the interaction of Hic-5 with P-JNK or P-MKK4 in cultured Hic-5 +/+ VSMCs using PLA assays. More red fluorescent dots were detected with the Hic-5 antibody in combination with the P-JNK antibody or P-MKK4 antibody in VSMCs after Ang II treatment than in those detected with the control (untreated with Ang II) ( Figure 7D ), suggesting that Hic-5 also contributes to the association of P-JNK and P-MKK4 in VSMCs.
Together, these results suggest that Hic-5 serves as a scaffold selective for p54 JNK and MKK4 in VSMCs and contributes to the activation of p54 JNK by binding to both MKK4 and p54 JNK ( Figure 7E ).
Discussion
We showed that Ang II-induced ROS promoted the expression of Hic-5 in VSMCs, which subsequently accelerated the phosphorylation of JNK, especially p54 JNK. Mechanistically, Hic-5 can bind to both p54 JNK and its upstream regulatory molecule, MKK4. Suppression of the p54 JNK pathway by Hic-5 loss resulted in the limited secretion of proMMP2 and MMP2 and expression of MT1-MMP, which led to protection from elastin degradation and subsequent AAA formation and rupture ( Figure 8 ). This study not only identified Hic-5 as a downstream molecule of ROS, which promotes AAA formation, but also suggested that Hic-5 can serve as a specific scaffold between MKK4 and p54 JNK in VSMCs.
Although numerous studies have clearly demonstrated that ROS play an important role in the development of aneurysms, no strong therapeutic strategy currently exists for the clinical benefits of antioxidant administration. One potential reason for this could be the crucial role of ROS in mediating the transduction of intracellular signals that are also important for regulating both VSMC and vascular functions. 33, 34 Our findings not only demonstrated that Hic-5, as a downstream molecule of ROS in the transduction of intracellular signals, regulates AAA development but also that its absence did not affect ROS production or normal function in mice. In addition, Hic-5 specifically binds to p54 JNK and its upstream molecule, MKK4, and plays an essential role in the phosphorylation of p54 JNK in VSMCs. Although the inhibition of JNKs has been considered as a potential therapeutic target for aneurysms, 17 JNKs have been shown to play critical roles in adult tissue homeostasis. In fact, the knockout of both Jnk1 and Jnk2 genes in mice was shown to be an embryonic lethal mutation. 35 Thus, targeting JNKs themselves may be limited to be used as a mainstream treatment approach. Therefore, the exact JNK isoform (JNK1 or JNK2) is required to be identified in aneurysm formation. We found that JNK2 is primarily composed of the p54 JNK isoform in cultured mouse VSMCs. In addition, Jnk2 deficiency in mouse VSMCs markedly inhibited the secretion of MMP2. 17 All these suggest that Hic-5-targeted therapy may be more specific for the treatment of aneurysms with minimum side effects. Paxillin, a member of paxillin family proteins together with Hic-5, has extensive homology with Hic-5 and is known to provide an efficient scaffold for the ERK module. 36 In the present study, we demonstrated that Hic-5 served as a scaffold for the p54 JNK module. These results raise the possibility that each paxillin family protein may behave as a respective scaffold for one of the MAPK modules. We also found that Hic-5 expressed in VSMCs, rather than other types of cells, was essential for the development of AAAs. A couple of molecules expressed in VSMCs have been proposed to initiate AAA development by promoting the secretion of MMP2 and inflammatory cell recruitment in aneurysm formation in mice and humans. 9, 25, 37 These studies strongly support our findings that VSMC-derived Hic-5 played a key role in the initiation of AAAs by promoting the secretion and activation of MMP2. Moreover, our results showed that Hic-5 was induced in the aorta in the early stage of Ang II-induced AAA formation. Although the Ang II-induced vascular inflammatory response contributes to AAA progression, Hic-5 deficiency did not affect the secretion of proinflammatory cytokines in VSMCs, and Hic-5 was also not expressed in mouse macrophages. In light of these findings, Hic-5 may not play a major role in inflammatory responses in AAA development. It has been previously reported that there are differences between human AAAs and Ang II-induced mouse AAAs including their location in the infrarenal versus suprarenal region, respectively; and aortic dissection is an early event in Ang II-induced mouse AAAs but not in human AAAs. 19 Previous studies have shown that an Ang II receptor blocker prevented aortic aneurysm dilatation in mouse and human Marfan syndrome (MFS). 38, 39 One of the major clinical manifestations of MFS is aortic aneurysm. Fibrillin-1 has been identified as the gene responsible for MFS. 40 Recently, elevated circulating TGF-b1 concentrations and the critical role of TGF-b-activated MAPK signaling were reported in human and mouse MFS, respectively. 41, 42 Hic-5 was originally identified as a TGF-b1-inducible gene; moreover, the Gene Coexpression Database, which is a database of comparative gene coexpression networks in mammals (http://www.coxpresdb.jp/), 43 revealed that fibrillin-1 and Hic-5 were spatiotemporally coexpressed in mice and humans. Therefore, it is reasonable to speculate that Hic-5 may play a key role in the development of MFS together with fibrillin-1. Future studies should focus on the role of Hic-5 in MFS using an appropriate animal model. 
